Search results
Found 1070 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
COVID-19: how to tackle vaccine hesitancy among BAME groups
Coronavirus COVID-19 General Research
22 March 2021
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Clinical Trials Coronavirus COVID-19 General Research
22 March 2021
A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective, adding to previous trial data from the United Kingdom, Brazil and South Africa, as well as real-world impact data from the United Kingdom.
Oxford awarded major funding to probe childhood poverty and social inequalities
Awards and Appointments General Research
19 March 2021
Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
Awards and Appointments General Innovation Research
18 March 2021
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Two doses of vaccine offer same protection from COVID as prior infection, study finds
Coronavirus COVID-19 General Research
15 March 2021
Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found.
Characterising SARS-CoV-2 genetic diversity and transmission
Coronavirus COVID-19 General Research
9 March 2021
Adaptive mutations of SARS-CoV-2 are rare and unlikely to be transmitted, but when they are transmitted they can have a big impact, finds a new study.
Rare Disease Day 2021: Pandemic response prepares us for next major challenge
General Research
9 March 2021
Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal
Awards and Appointments Coronavirus COVID-19 General Innovation Research
5 March 2021
Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.
PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine
Clinical Trials Coronavirus COVID-19 General Research
3 March 2021
From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.
Regular meat consumption linked with a wide range of common diseases
Research
2 March 2021
Regular meat consumption is associated with a range of diseases that researchers had not previously considered, according to a large, population-level study conducted by a team at the University of Oxford.
New data show vaccines reduce severe COVID-19 in older adults
Coronavirus COVID-19 Research
2 March 2021
New data show both Oxford / AstraZeneca vaccine and the Pfizer-BioNTech vaccines significantly reduce severe COVID-19 in older adults.
Singula Bio, a new Oxford spin-out company - Cancer need not be fatal
General Innovation Research
25 February 2021
Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.
Major rise in public support for COVID vaccine – Oxford study
Coronavirus COVID-19 General Research
24 February 2021
More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.
Three ways virtual reality could transform mental health treatment
General Research
22 February 2021
Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests
Coronavirus COVID-19 General Research
22 February 2021
The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
Reprogramming tumour cells using an antimalarial drug
General Research
18 February 2021
Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.
Oxford-led technology to help those at high risk from Covid-19
Coronavirus COVID-19 General Research
16 February 2021
More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus.
How monkeys and humans make novel choices
General Research
15 February 2021
Dr Alessandro Bongioanni, Postdoctoral Research Associate in the Department of Experimental Psychology, writes for the Oxford Science Blog on the way humans and other primates make first-time choices.
Exscientia and the University of Oxford announce partnership to develop treatments for Alzheimer’s disease
General Research
12 February 2021
Neuroinflammation collaboration targeting inflammasome steps-up-the-pace in race for Alzheimer’s disease medicines that alleviate the burden of devastating disease